Whitney Remily has more than 15 years of experience as a lawyer and registered patent agent. Her practice focuses on transactional work in the chemical field with a particular focus on rendering patent opinions and conducting other forms of due diligence and landscape analyses.

Whitney has significant experience with various patent matters relating to filings of Abbreviated New Drug Applications by generic drug manufacturers (including the provision of detailed statements and notice letters). In this context, she has handled more than 500 opinion matters, including issues relating to FDA exclusivity, new chemical entities, importation of active ingredients, synthetic intermediates, polymorphs, approved and off-label indications, finished formulations/compositions and drug products.

Whitney's practice also includes experience negotiating licenses, preparing and prosecuting patent applications (including patent term extensions) and counseling in patent litigation. In addition to pharmaceuticals, she has substantial experience in other technical areas including organic and inorganic chemistry, agrochemicals, cosmetics, diagnostics, polymers, food products, nutritional supplements, cigarettes, fine chemicals and medical devices.

Whitney previously worked at Merck & Co. as a synthetic organic chemist, where she was involved in the synthesis and development of pharmaceutical compounds. During her graduate studies in organic chemistry at the Johns Hopkins University, her research related to the synthesis of novel

anti-malarial and chemotherapeutic agents. While obtaining her undergraduate degree from Cornell University, she worked as a research assistant in both the Chemistry Department and the Material Science and Engineering Department.

Whitney has lectured on topics relating to opinion writing, patent searching, patent prosecution strategies and requirements under the America Invents Act.